Source: International Congress 2017 – Rare diseases
Disease area: Interstitial lung diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Oda (Yokohama, Japan). Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis. 1518

Member's Comments

No comment yet.

Related content which might interest you: Predictor factors of mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 The health status in idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Risk factors predicting mortality in patients with lung abscess Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 Predicting risk of postoperative pulmonary complications in children and adolescents with congenital heart defects after surgical repair Source: Annual Congress 2004 - Premature infants, respiratory morbidity and lung pathology in children Year: 2004 Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Survival and predictive factors of mortality in patients with bronchiectasis Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Risk factors for lung involvements in patients with Sjögren's syndrome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Study of the factors affecting the morbidity and mortality of the patients of bilateral haemorrhagic pneumonia Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Factors affecting mortality and morbidity in patients with bronchiectasis Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations Source: Eur Respir J, 59 (2) 2100949; 10.1183/13993003.00949-2021 Year: 2022 Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008 Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents Source: Eur Respir J 2014; 44: 523-527 Year: 2014 Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation Source: International Congress 2017 – PAH and CTEPH Year: 2017